• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过南威尔士神经内分泌肿瘤服务的转变实现小肠神经内分泌肿瘤(SI-NETs)的早期诊断。

Earlier diagnosis of small intestine neuroendocrine tumours (SI-NETs) through transformation of the South Wales NET service.

作者信息

Gould Harriet L, Amin Kapish, Karategos Thanos, Abbas Sarah, Olive Susannah, Sivananthan Mathoorika, Rela Ayeesha, Reed Harriet, Powell Catherine, Navaratnam Janu, Ellis-Owen Rwth, Fielding Patrick, Mondal Dipanjali, Kihara Steve, Williams Gethin, Morgan Carys, Witczak Justyna, Cornish Julie, Gwynne Sarah, Horwood James, Torkington Jared, Hargest Rachel, Christian Adam, Davies Michael, Ansell James, Khan Mohid S

机构信息

Cardiff University, Cardiff, UK.

South Wales Neuroendocrine Tumour Service, Department of Gastroenterology, Cardiff and Vale University Health Board, Cardiff, UK.

出版信息

J Neuroendocrinol. 2025 Apr;37(4):e13486. doi: 10.1111/jne.13486. Epub 2024 Dec 26.

DOI:10.1111/jne.13486
PMID:39726191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11975795/
Abstract

Small intestine neuroendocrine tumours (SI-NETs) are often diagnosed late with a UK median of 3 years and high misdiagnosis rates. Previous studies, largely based on patient surveys, offer little data on improving diagnosis. In 2017, the South Wales NET service underwent a nationally commissioned, systematic transformation, aiming to improve diagnosis through the development of a gastroenterology and surgical referral network, and education of these specialities. This study aims to assess the impact of the transformation on SI-NET diagnosis times and misdiagnosis rates using accurate hospital data, along with the diagnostic routes and investigations used for SI-NETs. We retrospectively analysed the hospital records of 224 patients diagnosed with SI-NETs referred to the South Wales NET service (110 pre-transformation and 114 post-transformation). Following the service transformation, there was a significant reduction in diagnosis times from a median of 12.5-5.2 months (p < .05), at an earlier stage (cases with metastases reduced from 77% to 62%), and reduced misdiagnosis rates from 40% to 25%. Colonoscopy, used to investigate the presenting gastrointestinal symptoms in 42% of patients prior to diagnosis, identified an abnormality in only 28%, compared with 97% with computed tomography (CT) scans. A gastroenterology and surgical referral network across hospitals may improve diagnosis in SI-NETs, leading to earlier detection and reducing misdiagnosis rates. Further exploration of GP interactions is needed. Caution is needed following negative colonoscopy in patients with persistent lower gastrointestinal symptoms as this could lead to missed SI-NET diagnosis if further abdominal imaging is not undertaken.

摘要

小肠神经内分泌肿瘤(SI-NETs)常常在晚期才被诊断出来,在英国,其中位诊断时间为3年,误诊率很高。以前的研究主要基于患者调查,提供的关于改善诊断的数据很少。2017年,南威尔士神经内分泌肿瘤服务进行了一项由国家委托的系统性变革,旨在通过建立胃肠病学和外科转诊网络以及对这些专业进行培训来改善诊断。本研究旨在利用准确的医院数据评估这一变革对SI-NET诊断时间和误诊率的影响,以及SI-NETs的诊断途径和所采用的检查方法。我们回顾性分析了224例被诊断为SI-NETs并转诊至南威尔士神经内分泌肿瘤服务的患者的医院记录(变革前110例,变革后114例)。服务变革后,诊断时间显著缩短,从12.5个月的中位数降至5.2个月(p < 0.05),且诊断阶段更早(有转移的病例从77%降至62%),误诊率从40%降至25%。在诊断前,42%的患者接受结肠镜检查以调查出现的胃肠道症状,其中仅28%发现异常,而计算机断层扫描(CT)扫描的发现异常率为97%。跨医院的胃肠病学和外科转诊网络可能会改善SI-NETs的诊断,从而实现更早发现并降低误诊率。需要进一步探索全科医生的互动情况。对于持续存在下消化道症状的患者,结肠镜检查结果为阴性后需谨慎,因为如果不进行进一步的腹部影像学检查,可能会导致SI-NET诊断遗漏。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4815/11975795/bda18df7ca8c/JNE-37-e13486-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4815/11975795/a8eba479e1fe/JNE-37-e13486-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4815/11975795/7b2988b80c45/JNE-37-e13486-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4815/11975795/553949f38f24/JNE-37-e13486-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4815/11975795/bda18df7ca8c/JNE-37-e13486-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4815/11975795/a8eba479e1fe/JNE-37-e13486-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4815/11975795/7b2988b80c45/JNE-37-e13486-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4815/11975795/553949f38f24/JNE-37-e13486-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4815/11975795/bda18df7ca8c/JNE-37-e13486-g002.jpg

相似文献

1
Earlier diagnosis of small intestine neuroendocrine tumours (SI-NETs) through transformation of the South Wales NET service.通过南威尔士神经内分泌肿瘤服务的转变实现小肠神经内分泌肿瘤(SI-NETs)的早期诊断。
J Neuroendocrinol. 2025 Apr;37(4):e13486. doi: 10.1111/jne.13486. Epub 2024 Dec 26.
2
Prevalence of metastases outside the liver and abdominal lymph nodes on Ga-DOTATOC-PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours.小肠和胰腺神经内分泌肿瘤患者经镓- DOTATOC - PET/CT检查发现的肝脏外及腹部淋巴结转移的患病率
J Neuroendocrinol. 2024 May;36(5):e13391. doi: 10.1111/jne.13391. Epub 2024 Apr 9.
3
Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital.在一家转诊医院接受手术治疗的小肠类癌患者的生存和疾病复发情况。
Surg Oncol. 2020 Dec;35:336-343. doi: 10.1016/j.suronc.2020.09.015. Epub 2020 Sep 18.
4
Incidence and prognosis of patients with small intestinal neuroendocrine tumors in a population based nationwide study.基于人群的全国性研究中小肠神经内分泌肿瘤患者的发病率和预后。
Cancer Epidemiol. 2022 Aug;79:102197. doi: 10.1016/j.canep.2022.102197. Epub 2022 Jun 16.
5
Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors.Ma2 副肿瘤抗原自身抗体作为特异性血液生物标志物,用于检测小肠神经内分泌肿瘤的早期复发。
PLoS One. 2010 Dec 30;5(12):e16010. doi: 10.1371/journal.pone.0016010.
6
Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasms.IV 期小肠神经内分泌肿瘤患者的相关预后因素。
J Neuroendocrinol. 2022 Jan;34(1):e13076. doi: 10.1111/jne.13076. Epub 2021 Dec 28.
7
Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours.恶性小肠神经内分泌肿瘤中的褪黑素免疫反应。
PLoS One. 2016 Oct 13;11(10):e0164354. doi: 10.1371/journal.pone.0164354. eCollection 2016.
8
Evidence for a heritable contribution to neuroendocrine tumors of the small intestine.遗传因素对小肠神经内分泌肿瘤影响的证据。
Endocr Relat Cancer. 2016 Feb;23(2):93-100. doi: 10.1530/ERC-15-0442. Epub 2015 Nov 24.
9
Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors.主成分分析、层次聚类以及对血浆mRNA和激素水平的决策树评估,作为小肠神经内分泌(类癌)肿瘤的早期检测策略。
Ann Surg Oncol. 2009 Feb;16(2):487-98. doi: 10.1245/s10434-008-0251-1. Epub 2008 Dec 3.
10
Presenting Symptoms and Delay in Diagnosis of Gastrointestinal and Pancreatic Neuroendocrine Tumours.胃肠道和胰腺神经内分泌肿瘤的临床表现和诊断延误。
Neuroendocrinology. 2018;107(1):42-49. doi: 10.1159/000488510. Epub 2018 Mar 18.

本文引用的文献

1
The impact of COVID-19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients.COVID-19 对神经内分泌肿瘤(NET)管理的影响:一项针对 NET 患者和治疗 NET 患者的医护人员的国际 NET CONNECT 调查。
J Neuroendocrinol. 2022 Oct;34(10):e13196. doi: 10.1111/jne.13196. Epub 2022 Sep 7.
2
Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the British Society of Gastroenterology (BSG).疑似结直肠癌(CRC)体征或症状患者的粪便免疫化学检测(FIT):英国和爱尔兰结直肠外科学会(ACPGBI)与英国胃肠病学会(BSG)联合指南
Gut. 2022 Jul 12;71(10):1939-62. doi: 10.1136/gutjnl-2022-327985.
3
Neuroendocrine tumours: what gastroenterologists need to know.神经内分泌肿瘤:胃肠病学家需要了解的内容。
Frontline Gastroenterol. 2020 Sep 22;13(1):50-56. doi: 10.1136/flgastro-2020-101431. eCollection 2022.
4
Interventions to improve early cancer diagnosis of symptomatic individuals: a scoping review.改善有症状个体早期癌症诊断的干预措施:范围综述。
BMJ Open. 2021 Nov 9;11(11):e055488. doi: 10.1136/bmjopen-2021-055488.
5
Impact of the COVID-19 pandemic on neuroendocrine tumour services in England.新冠疫情对英格兰神经内分泌肿瘤服务的影响。
Endocrine. 2021 Jan;71(1):14-19. doi: 10.1007/s12020-020-02564-2. Epub 2021 Jan 5.
6
Professional Assessment of the Impact of COVID-19 on Handling NET Patients.新型冠状病毒肺炎(COVID-19)对神经内分泌肿瘤(NET)患者治疗影响的专业评估
J Clin Med. 2020 Nov 11;9(11):3633. doi: 10.3390/jcm9113633.
7
Have large increases in fast track referrals improved bowel cancer outcomes in UK?英国快速通道转诊人数的大幅增加是否改善了肠癌治疗效果?
BMJ. 2020 Nov 10;371:m3273. doi: 10.1136/bmj.m3273.
8
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet).SARS-CoV2 大流行传播对意大利神经内分泌肿瘤诊治的影响:意大利神经内分泌肿瘤学会(Itanet)报告。
J Endocrinol Invest. 2021 May;44(5):989-994. doi: 10.1007/s40618-020-01393-4. Epub 2020 Aug 16.
9
GP access to FIT increases the proportion of colorectal cancers detected on urgent pathways in symptomatic patients in Nottingham.全科医生获得 FIT(粪便免疫化学检测)可增加诺丁汉有症状患者中通过紧急途径检测到的结直肠癌比例。
Surgeon. 2021 Apr;19(2):93-102. doi: 10.1016/j.surge.2020.03.002. Epub 2020 Apr 20.
10
Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013-2015.神经内分泌形态对癌症结局和诊断时分期的影响:2013-2015 年英国全国队列研究。
Br J Cancer. 2019 Nov;121(11):966-972. doi: 10.1038/s41416-019-0606-3. Epub 2019 Oct 25.